Related Experiment Videos
Hyperparathyroidism among atomic bomb survivors in Hiroshima
S Fujiwara1, R Sposto, H Ezaki
1Department of Clinical Studies, Radiation Effects Research Foundation, Hiroshima City, Japan.
Radiation Research
|June 1, 1992
Summary
Atomic bomb radiation exposure increases hyperparathyroidism risk, particularly in younger individuals. This study highlights potential risks from lower radiation doses, impacting endocrine health.
Area of Science:
- Endocrinology
- Radiation Epidemiology
- Public Health
Background:
- Hyperparathyroidism is a condition affecting parathyroid hormone levels.
- Atomic bomb survivors provide a unique cohort for studying long-term radiation effects.
Purpose of the Study:
- To investigate the association between atomic bomb radiation exposure and hyperparathyroidism incidence.
- To determine if radiation dose influences hyperparathyroidism prevalence.
Main Methods:
- A population-based study of 3,948 atomic bomb survivors and controls in Hiroshima.
- Diagnosis of hyperparathyroidism based on histopathology, hypercalcemia, and parathyroid hormone levels.
- Statistical analysis adjusted for sex and age at bombing, examining dose-response relationship.
Main Results:
- Nineteen cases of primary hyperparathyroidism were diagnosed.
- Prevalence was threefold higher in females than males.
- Hyperparathyroidism rates significantly increased with radiation dose (P < 0.001), with a relative risk of 4.1 at 1 Gy.
- Evidence suggests a stronger radiation effect in those younger at the time of exposure.
Conclusions:
- Atomic bomb radiation exposure is a significant risk factor for hyperparathyroidism.
- Even low radiation doses, below radiotherapy levels, may induce hyperparathyroidism.
- Findings underscore the long-term health implications of radiation exposure on endocrine function.